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Abstract 
Reversible inhibition, irreversible inhibition, and activation of calf intestinal 
alkaline phosphatase (EC 3.1.3.1) have been studied by capillary 
electrophoresis. The capillary electrophoretic enzyme-inhibitor assays were 
performed by electrophoretically mixing zones of inhibitor and enzyme in a 
substrate-filled capillary. Enzyme inhibition was indicated by a decrease in 
product formation detected in the capillary by laser-induced fluorescence. 
Reversible enzyme inhibitors could be quantified by Michaelis-Menten treatment 
of the electrophoretic data. Reversible, competitive inhibition of alkaline 
phosphatase by sodium vanadate and sodium arsenate has been examined. The 
calculated K; value for the capillary electrophoretic enzyme-inhibitor assays was 
2.1 µM for sodium vanadate and 21 µM for sodium arsenate. The limit of 
detection for sodium vanadate was 3 µM, and the limit of detection for sodium 
arsenate was 10 µM. Reversible, non-competitive inhibition of alkaline 
phosphatase by theophylline has been studied. The calculated K; value for the 
capillary electrophoretic enzyme-inhibitor assays for theophylline was 102 µM, 
and the limit of detection was 3 µM. Irreversible inhibition of alkaline phosphatase 
by EDTA at concentrations of 1.0 mM or higher has been observed. Activation of 
alkaline phosphatase has also been observed for EDTA at con�ntrations from 
20 to 400 µM. 
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Chapter 1 
Introduction to Enzyme Assays 
1.1 Enzyme Assays 
Enzymes are large proteins that are found in biological systems and 
catalyze a wide variety of chemical reactions (1 ). Enzymes have an affinity for 
specific substrates, and the chemical structure of the substrate as well as its 
concentration will affect enzyme-catalyzed reaction rate of the substrate to form 
product (1 ). The substrate binds to the enzyme at a specific place called the 
active site. The active site is where the substrate is converted to product (2). The 
enzyme-catalyzed reaction may also depend on a cofactor, small inorganic ions 
(i.e. Mg+2 and zn+2), or a coenzyme, an organic molecule (i.e. NAO+, 
nicotinamide adenine dinucleotide). The cofactors or coenzymes are bound 
tightly to the enzyme at a particular site on the protein molecule. The enzyme­
catalyzed reaction rate also depends on other factors such as temperature, 
buffer composition, solvent, pH, and enzyme stability (3). 
Figure 1 .1 shows the general reaction scheme for an enzyme-catalyzed 
reaction. The velocity (v) of the reaction of substrate can be determined by 
plotting the concentration of product formed versus time. The rate of the reaction 
is as follows: 
v = d[P] / dt = k2 [ES] (1a) 
1 
Reaction of enzyme with substrate 
k1 k2 
E + S ... .,, ES ... .,, E + P 


















Figure 1.1. General enzyme-catalyzed reaction scheme 
2 
where d[P]/dt is formation of product over time, k2 is the rate constant for the 
formation of product, and [ES] is the concentration of enzyme-substrate 
complex. Figure 1.1 shows the formation of product over time. Since only the 
initial rate of the reaction once steady state is reached is considered, the reaction 
where product (P) and the enzyme (E) form ES can be ignored (involving the rate 
constant k2) due to the small concentration of P initially (1 ). The reaction velocity 
is defined by the second step of the reaction in Figure 1.1 because it is the 
slowest step. The maximum velocity for the enzyme-catalyzed reaction is 
reached when all the enzyme is in the form of the enzyme-substrate complex. 
When the concentration of the enzyme-substrate complex is essentially constant 
because the rate of formation and disappearance of the enzyme-substrate 
complex is basically the same, this is then considered steady state. The reaction 
kinetics of the enzyme-catalyzed reactions in steady-state can be described by 
the following equation: 
v = (Vmax [SJ) I (Km + [SJ) (1 b) 
where V max is the maximum velocity of the reaction with an enzyme and a 
specific substrate, [S] is the concentration of substrate, Km is the Michaelis­
Menten constant, and v is the reaction velocity (1, 2). This equation is known as 
the Michaelis-Menten equation and be can be rearranged as follows: 
1 IV = 11 V max + (Km / V max) I [SJ ( 1 c) 
Equation 1 c is called the Lineweaver-Burk equation, and a plot of v-1 versus [sr1 
is called a Lineweaver-Burk plot or double-reciprocal plot (2). Measuring the rate 
of the reaction, v, at different substrate concentrations and plotting the data using 
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the Lineweaver-Burk equation will allow the determination of V max from the y­
intercept and Km from the slope of the line. Figure 1.1 shows an example of a 
Lineweaver-Burk plot. 
The rate of the enzyme-catalyzed reaction can be monitored by measuring 
either product formation or disappearance of substrate using several detection 
methods such as absorbance (4), fluorescence (4), and electrochemical 
detection (5-7). The reaction can be initiated by either adding the enzyme to a 
mixture containing all required chemicals such as the substrate, buffer, enzyme, 
cofactors, or coenzyme and monitoring the reaction or adding the substrate to a 
mixture with the required chemicals (3). The initial rate of the reaction, v, is 
determined from the initial, linear part of the curve (Figure 1.1) of a plot of 
product concentration versus time or substrate concentration versus time (3). For 
example, alcohol dehydrogenase (ADH) reacts with ethanol to form acetaldehyde 
(8). Alcohol dehydrogenase requires the coenzyme NAO+ in order to catalyze the 
reaction of ethanol to actealdehyde. During the reaction, NAO+ is converted to 
NADH (nicotinamide adenine dinucleotide, reduced form). The reaction is as 
follows: 
ADH 
CH3CH20H + NAO+ � CH3CHO + NADH + H+ (1d) 
To determine the kinetic factors ( V max and Km) for the reaction of ethanol with 
ADH, a traditional experiment would be as follows. Ethanol and NAO+ would be 
added to a cuvette. The cuvette would then be placed in a UVNIS spectrometer. 
Then the ADH is added to the cuvette, and the concentration of NADH is 
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monitored by absorbance at 340 nm. The plot of NADH concentration versus 
time would be similar to the plot in Figure 1.1. The slope of the initial, linear part 
of the curve would be used to determine vat the specific concentration of the 
substrate, ethanol (with NAO+ in excess). The same experiment would be 
performed at several concentrations of ethanol as the limiting reagent in order to 
construct a Lineweaver-Burk plot (Figure 1.1) to determine Vmax and Km for the 
ADH-catalyzed reaction of ethanol. Such experiments can be performed at a 
smaller scale and in parallel using microwell plates (e.g. 96; 384 wells/plate), but 
the experiments are effectively identical to a series of experiments performed in a 
standard cuvette. 
1.2 Enzyme Inhibition 
Enzymes catalyze the reaction of a specific substrate. Enzyme inhibition 
occurs when another substance interferes in the enzyme-catalyzed reaction. The 
inhibitor will cause the rate of reaction to decrease. The inhibitor may also 
inactivate the enzyme completely (1). 
Enzyme inhibition is important in many scientific areas including pesticide 
science and pharmacology. Enzyme inhibitors are developed. as pesticides to 
protect crops from damage caused by insects (9, 10). Compounds are designed 
to inhibit specific enzymes for medical applications (11, 12). For example, metal 
complexes developed to inhibit enzymes are used as drugs to treat cancer, 
hypertension, and arthritis (13). Many chemical analysis methods have been 
developed using enzyme inhibition reactions. Environmental pollutants, 
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organophosphorus pesticides, and heavy metal ions have all been studied 
through inhibition of reactions catalyzed by various enzymes (1 4). 
There are two types of inhibition: reversible and irreversible (1 ). In 
reversible inhibition, once the inhibitor is removed, the enzyme activity will return 
to its previous level. There are several different types of reversible inhibitors­
competitive, noncompetitive, and uncompetitive (1 ). Figure 1 .2 presents the 
reaction pathways the different types of reversible inhibitors can follow (2). In 
Figure 1 .2, K; is the dissociation-constant of the enzyme-inhibitor complex and 
indicates how strong an inhibitor is for a particular enzyme. 
A competitive inhibitor binds to the active site and will only bind to the free 
enzyme. A competitive inhibitor will also likely resemble the substrate structurally 
(1 ). The following equation based on the Michaelis-Menten equation describes 
the kinetics for a competitive inhibitor (1 5): 
V;,c = {V max [SJ} I {Km (1 + [/J • K;,c-1) + [SJ} (1 e) 
When Equation 1 e  is rearranged into the form of the Lineweaver-Burk equation, 
and 1 /v versus 1 /[S] is plotted at different concentrations of inhibitor, it is 
determined that the Vmax will not change, but the Km will change as a function of 
[I]. The V max stays the same because at high enough concentrations of substrate 
the effect of the inhibitor will disappear, but the Km value is affected. From the 
slope of the Lineweaver-Burk plot for a competitive inhibitor, the Km value 
appears as an apparent Km. as described by the following equation: 
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+ + 
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Figure 1.2. Reaction pathways for reversible inhibitors 
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A noncompetitive inhibitor does not bind to the active site but somewhere 
else on the enzyme. The noncompetitive inhibitor can bind with either the 
enzyme or the enzyme-substrate complex (1). The following equation describes 
the kinetics of a noncompetitive inhibitor (15): 
V;,nc = fVmax [SJ} I {Km (1 + [JJ • K;,nc-1) + [SJ (1 + [JJ • K;,nc-1)} (1g) 
If Equation 1 g is rearranged in the form of a Lineweaver-Burk plot and 1 Iv versus 
1 l[S] is plotted at different concentrations of inhibitor, it is determined that the Km 
will not change but the V max will. This because the inhibitor will prevent some 
fraction of enzyme from being able to catalyze the reaction of substrate to form 
product without affecting Km . The apparent V ma/ can be described by the 
following equation: 
1 /Vma/ = (1 /VmaxKJ [JJ + 1 /Vmax (1 h) 
An uncompetitive inhibitor will only bind with the enzyme-substrate 
complex. Inhibition caused by uncompetitive inhibitors with a single substrate is 
rare, but ·is seen more often in reactions with multiple substrates (1 ). The 
equation to describe uncompetitive inhibition is as follows: 
V;,uc = fVmax [SJ} I {Km + [SJ (1 + [JJ • K;,uc-1)} (1 i) 
from rearrangement of Equation 1 i in the form of the Lineweaver-Burk plot of 1 Iv 
versus 1l[S] and plotting at different inhibitor concentrations, it is determined that 
Vmax and Km are both affected by an uncompetitive inhibitor (15). 
In irreversible inhibition, once the inhibitor is removed, the enzyme activity 
will not increase (1 ). Many irreversible inhibitors can form a covalent bond with a 
particular functional group of an amino acid in the protein structure of the 
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enzyme, and thus change the enzyme conformation or affect the active site 
geometry and cause the enzyme activity decrease. Some enzymes contain 
cofactors and can be irreversibly inhibited by using a metal chelator to remove 
the cofactor from the enzyme. The initial enzyme activity will only return if the 
metal cofactor is added back to the enzyme. If the cofactors or coenzymes are 
removed and not to bound the enzyme, the enzyme is inactivated and is called 
an apoenzyme. Irreversible inhibitors have been used as tools to learn more 
about enzyme active sites and enzyme mechanisms (1 ). The detailed kinetics of 
irreversible inhibitors are more complex and difficult to study compared to 
reversible inhibitors. Often the percentage of the activity of the enzyme remaining 
versus time at different concentrations of inhibitor can show how strong the 
irreversible inhibition is (16-19). Also the rate constants for irreversible inhibition 
can be determined by a complex method called the Tsou method (18, 19). 
1.3 On-line Enzyme Assays 
Capillary electrophoresis has emerged as a versatile tool for enzyme 
analysis (20, 21 ). Homogeneous on-column capillary electrophoretic enzyme 
assays, where the enzyme is injected into the capillary as a discrete zone, offer 
several advantages. These include simplicity, rapid analysis times, minimal 
sample preparation, and consumption of extremely small amounts of enzyme 
(20, 21 ). Single enzyme molecules have been detected and studied (22, 23), and 
separation and detection of isoenzymes from single cells have been reported 
(24 ). Either the substrate or enzyme concentration can be quantified (8, 20, 25, 
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26), and Michaelis-Menten constants can be determined (27-31 ) .  Peptide 
mapping using on-column enzyme d igestion has also been demonstrated (32) , 
and enzymatic d igestion of oligonucleotides has been stud ied (33) . 
The first on-column capi llary electrophoretic enzyme assays, which 
described by Bao and Regnier (25) , were performed by injecting a zone of 
enzyme into a capil lary fi lled with substrate and the required coenzyme for the 
catalyzed reaction . Product was formed as the enzyme migrated through the 
capil lary, and the product was detected at a downstream absorbance detector. 
This type of assay, based on a reaction carried out in a CE column, was later 
termed electrophoretically med iated microanalysis (EMMA) , and this specific 
format was defined as "continuous-engagement" EMMA (34, 35). Capil lary 
electrophoretic enzyme assays have also been carried out by injecting the 
enzyme and substrate as two separate zones and allowing the zones to mix 
electrophoretica lly (36) . Product was formed when the enzyme and substrate 
zones mixed electrophoretically, and this product was detected as a separate 
zone. This format was defined as "transient-engagement" EMMA (34, 35) . 
Figure 1 .3 i l lustrates both types of EMMA. 
Enzyme assays based on EMMA have been used to quantify enzyme and 
substrate , to determine Michael is-Menten constants, and to determine enzyme 
activity (20, 2 1 , 25, 30) (34, 35, 37-43) . Enzyme assays have been developed 
using microchip devices (44) . Many of these enzyme assays on microchip 
devices uti l ize electrophoretic mixing of reagents (EMMA) (28, 44-47). Capillary 
1 0  
"Continuous-engagement" EMMA 
1 .  Substrate-Fi l led Capil lary 
... 






Product forms as enzyme migrates through the substrate-fi lled capillary. 
"Transient-engagement" EMMA 
Zones of enzyme(E) and substrate(S) are injected onto the capil lary. 
2 . .----
: 
___ _.__I e____,,s I ____ ____ 
The enzyme and substrate mix electrophoretically and wi l l form product(P) . 
3. 
The zones wil l  electrophoretically separate and be detected . 
Figure 1 .3. Description of the two types of EMMA 
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electrophoresis and electrophoretic microchip devices have also been used to 
study enzyme reactions by incubating reagents together, injecting an aliquot of 
the reaction mixture into a capil lary or onto a microch ip, and separating and 
detecting product formed during the incubation prior to injection (20, 21 , 48-53) . 
1 .4 On-l ine Enzyme-Inhibition Assays 
Capil lary electrophoresis and electrophoretic microchip devices have been 
used to study enzyme inhibition . A combination of "continuous-engagement" 
EMMA and "transient-engagement" EMMA techniques has been developed to 
study enzyme inhibition by CE (54) . In these experiments, the running buffer 
contained erythro-9-(2-hydroxy-3-nonyl)adenine, a competitive inh ibitor of 
adenosine deaminase. The substrate was adenosine. The product, inosine ,  was 
formed when the ind ividually injected enzyme and substrate zones mixed 
electrophoretically in the capi llary.  I n  these experiments, the same inh ibitor 
concentration was used throughout all of the experiments, while the substrate 
concentration was varied . The substrate and the enzyme solutions were 
preincubated independently with the inhibitor for 1 0  min before injection . When 
the injected enzyme and substrate zones had mixed electrophoretically in the 
capi l lary, the enzyme was allowed to incubate with the substrate at zero potential 
for 5 min . The h igh voltage was applied again, and the product was separated 
and detected by absorbance at 254 nm. Lineweaver-Burk plots for the data were 
used to determine the K; for erythro-9-(2-hydroxy-3-nonyl)adenine. 
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"Transient-engagement" EMMA method was used to study the inhibition of 
rhodanese by 2-oxoglutarate (55). The enzyme-catalyzed reaction requires two 
substrates, thiosulfate and cyanide. In the reaction, a sulfur from the thiosulfate 
ion is transferred to the cyanide ion to form the product, thiocyanate. The CE 
experiment is performed by injecting a zone of the enzyme and a separate zone 
containing the substrates and inhibitors, which are preincubated together before 
injection. Bromide was also used as an internal standard. The product, 
thiocyanate, was detected by UVNIS absorbance. The Ki values for the inhibitor 
as well as the type of inhibition with respect to each of the substrates were 
determined for each inhibitor. 
Enzyme inhibition has also been studied using electrophoretic mixing in 
microchip devices (27-29). The first report of this type of assay using continuous­
engagement EMMA was for the enzyme, �-galactosidase (28). The fluorogenic 
substrate, resorufin �-d-galactopyranoside, was used, and the competitive 
inhibitor, phenylethyl �-d-thiogalactoside, was studied. Substrate, buffer, enzyme, 
and inhibitor were contained in separate reservoirs on the microchip device and 
were mixed in  the device by electrokinetic transport control led by appl ied 
potentials. The substrate concentration was controlled by mixing substrate and 
buffer in the device under potential control. Enzyme and inhibitor solutions at 
fixed concentrations were subsequently mixed with the diluted substrate solution, 
and product formation was detected in the final reaction channel at a 
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downstream LIF detector. The Ki was determined for phenylethyl �-d­
thiogalactoside, and inhibition by two additional inhibitors was detected. 
A related microchip assay was developed for observing protein kinase A 
inhibition by H-89, a known competitive protein kinase A inhibitor (27) . The 
substrate was fluorescently labeled Kemptide, a heptapeptide that is not 
fluorogenic. In these experiments, the inhibitor was diluted on the microchip 
device and mixed with fixed concentrations of enzyme and substrate. Aliquots of 
the sample stream containing enzyme, substrate, and inhibitor were injected on 
the microchip device by into a separation channel after 75 seconds of incubation 
in an incubation channel. Then, the product and substrate were separated 
electrophoretically and detected by fluorescence. The K; value for the inhibitor 
was determined. 
A microchip assay was applied to study inhibition of acetylcholinesterase 
using acetylthiocholine as a substrate (29). Competitive and irreversible 
acetylcholinesterase inhibitors were examined using continuous-engagement 
EMMA. The enzyme was continuously pumped through the microchip device. 
Substrate was added to the enzyme stream. The product of the enzyme reaction 
is not fluorescent; therefore, coumarinylphenylmaleimide was added on-column 
after product formation to derivatize the product for LI F detection. Discrete zones 
of inhibitor were injected into the enzyme stream before the point of substrate 
addition, and inhibition was indicated by a decrease in fluorescent product 
formation as the inhibitor zone migrated to the detector. The K; was determined 
for the competitive inhibitor, tacrine. Using this method, reversible and 
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irreversible inhibitors could be analyzed and distinguished. Separation and 
detection of a mixture of inhibitors was demonstrated. 
Presented here, different classes of alkaline phosphatase inhibitors have 
been investigated by CE using a combination of continuous-engagement EMMA 
and transient-engagement EMMA. These inhibitors include a non-competitive, 
reversible inhibitor (theophyl line), competitive, reversible inhibitors (sodium 
vanadate and sodium arsenate) and an irreversible inhibitor (EDTA) . 
Theophyl line, sodium vanadate, and sodium arsenate were quantified, and their 
K; values were determined. The activity change of the enzyme was quantified for 
experiments with EDTA. The specific enzyme studied was alkaline phosphatase 
(EC 3 . 1 .3 . 1 from calf intestine) . 
1 5  
Chapter 2 
Capi l lary Electrophoretic Analysis of Alkal ine Phosphatase 
Inh ibition by Theophyl l ine 
2.1 Introduction 
An on-column capillary electrophoretic enzyme-inhibition assay with 
fluorescence detection was developed to study the inhibition of alkaline 
phosphatase by theophylline. Theophylline is a non-competitive, reversible 
inhibitor of alkaline phosphatase (56). Reported K; values for theophylline with 
alkaline phosphatase range from 78 µM for bovine liver alkaline phosphatase to 
1 35 µM for serum alkaline phosphatase (57, 58). Theophylline is a clinically 
important compound that is used as a bronchodilator, respiratory stimulant, anti­
inflammatory drug, and for apnea treatment (59-61 ). The inhibition of alkaline 
phosphatase by theophylline is a good model system for developing these online 
enzyme-inhibitor assays because theophylline inhibition of alkaline phosphatase 
has been studied extensively, and it is potent inhibitor of this enzyme. Its 
reversible behavior would be easily observed in the electropherogram. 
Described here is the initial development of the on-column capillary 
electrophoretic enzyme-inhibition assay using the inhibition of alkaline 
phosphatase by theophylline. In the enzyme-inhibition assay presented in this 
chapter, the capillary is filled with a fluorogenic substrate. Next, separate zones 
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of the inhibitor and enzyme are injected. As the zones of the inhibitor and 
enzyme migrate through the capillary at a constant applied potential, product is 
continuously formed. When the zones of inhibitor and enzyme mix, the product 
formation decreases. When the zones of inhibitor and enzyme disengage, the 
product formation returns to its previous level. 
2.2 Experimental 
2.2. 1 Reagents 
Alkaline phosphatase (EC 3.1.3.1 from calf intestine) was purchased from 
ICN Biomedicals (Aurora, OH). AttoPhos ([2,2' -bibenzothiazol]-6-hydroxy­
benzathiazole phosphate) was obtained from Promega (Madison, WI). 
Theophylline (99%) and diethanolamine (DEA) were supplied by Acros 
(Pittsburgh, PA). All solutions and buffers were prepared in ultrapure water (> 18 
MO•cm, Barnstead E-pure System , Dubuque, IA). 
2.2.2 CE-LIF Instrumentation and Experimental Conditions 
The capillary electrophoresis instrument with laser-induced fluorescence 
detection (CE-LIF) was constructed in-house. The 457.9 nm line of a Coherent 
INNOVA 90C-5 argon ion laser (Santa Clara, CA) was used for excitation. The 
laser beam was focused onto the capillary by a fused-silica piano convex lens (f 
= 15.0 mm) (Optosigma, Santa Ana, CA). The power of the laser beam at the 
capillary was 35 mW. The fluorescence was collected at 90
° 
to the laser beam by 
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a 20X microscope objective (Edmund, Barrington, NJ) and was filtered by a 560 
± 10 nm bandpass filter (Oriel, Stratford, CT). A 1 mm diameter aperature (Oriel) 
was used as a spatial filter. Fluorescence was detected by a PMT (HC 120, 
Hamamatsu, Bridgewater, NJ) at 750 V. The PMT output was filtered by a low­
pass filter at 50 Hz, and then sent to an analog-to-digital board (Lab-PC-1200, 
National Instruments, Austin, TX). A LabVIEW program (National Instruments) 
was written in-house for data acquisition. The sampling rate was 10 Hz. The data 
were analyzed using Excel (Microsoft) and Peakfit (SPSS Inc. , Chicago, IL). A 
Spellman high-voltage power supply (CZE 1 OOOR, Hauppauge, NY) was used for 
the electrophoresis system. Fused silica capillaries with a 50 µm i.d. and 220 µm 
o.d. (SGE, Austin, TX) were utilized. The detection window was made by burning 
away the polyimide coating. 
The running buffer contained 50 mM DEA at pH 9.5 and 0. � 0 mM 
AttoPhos, a fluorogenic alkaline phosphatase substrate. The enzyme solution 
contained 0.18 nM alkaline phosphatase and 50 mM DEA buffer at pH 9.5. The 
running buffer and enzyme solution were prepared fresh daily. In addition to the 
inhib itor, the inh ib itor solutions contained 0 . 1 0  mM AttoPhos and 50 mM DEA at 
pH 9.5. The applied electric field was 310 V/cm for all separations and injections. 
All injections were performed electrokinetically. The electrode and capillary were 
rinsed externally with 50 mM DEA buffer at pH 9.5 before and after each injection 
in order to prevent cross contamination of the running buffer, enzyme solution 
and inhibitor solutions. 
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The capillary was thermostatted by enclosing the capillary from the 
injection end to the detection window in Teflon tubing (1.6 mm i.d.; 3.2 mm o.d.} 
(Nalgene, Rochester, NY) and flowing heated N2 gas (40 °C) through the Teflon 
tubing around the capillary. To ensure that the air flowed evenly over the entire 
thermostatted section of the capillary, two pieces of Teflon tubing of equal length 
were placed over the capillary from the injection end to the detection window. 
The two pieces of Teflon tubing were connected by a T-union Swagelock fitting. 
The third connection to the T-union was the tubing from the heated N2 source. 
The end of the tubing at the injection end of the capillary and at the detection 
window were sealed with Duca cement. To allow air flow, two small holes were 
placed in the Teflon tubing at equal distances from the injection end and the 
detection window. This reduced evaporation of solution in the buffer reservoirs by 
directing N2 flow away from the reservoirs. At the injection end, 1 cm of the 
capillary was not enclosed in Teflon tubing. 
2.2.3 Microplate Experiments 
Experiments were performed using a FLUOstar microplate fluorometer 
(BMG, Durham, NC). The excitation filter was centered at 450 nm, and the 
emission filter was centered at 555 nm. The instrument was thermostatted at 25 
°C. Microplates used were 96-well plates from Nunc (V-96 Polypropylene 
MicroWell Plate, Roskilde, Denmark). For the inhibitor assays, each well 
contained final concentrations of 0.10 mM AttoPhos, 50 mM DEA at pH 9 .5 ,  and 
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the inhibitor at various concentrations. For the assays used to generate 
Lineweaver-Burk plots, each well contained a final concentration of 50 mM DEA 
at pH 9.5, and AttoPhos at various concentrations. Each well contained a final 
volume of 200 µL. For all enzyme assays, 10  µL of alkaline phosphatase were 
injected into each well separately by the instrument to give a final concentration 
of 0.1 8 nM. The product formation was measured at 0.1 s intervals. 
2.3 Results and Discussion 
2.3. 1 On-column Capillary Electrophoretic Assay of Alkaline Phosphatase 
Alkaline phosphatase has been the subject of several studies using on­
column capillary electrophoretic enzyme assays. EMMA has been used to 
observe the catalyzed reaction between alkaline phosphatase and the 
substrates, p-aminophenylphosphate and p-nitrophenylphosphate (62). 
Michaelis-Menten constants for alkaline phosphatase have been determined 
using the EMMA technique (30). Catalysis by single alkaline phosphatase 
molecules has been studied using CE (63). 
Figure 2.1 presents the results of an alkaline phosphatase enzyme assay 
without inhibitor. The assay in Figure 2.1 was performed by injecting a 3.0 s zone 
of 0.1 8 nM alkaline phosphatase at a potential of 1 7.8 kV (31 0 V/cm). Then a 
constant potential of 1 7.8 kV (31 0 V/cm) was applied, and the product formed 
continuously as the alkaline phosphatase-AttoPhos complex migrated through 
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Figure 2.1 . Electropherogram of an alkal ine phosphatase enzyme 
assay with no inhibitor 
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diethanolamine and AttoPhos at a pH of 9.5 produced a current around 1 0  µA 
during electrophoresis. 
The peak at the end of the plateau at 4.4 min (Figure 2. 1 )  is an artifact 
resulting from product formation after then enzyme has been injected into the 
capillary and before the high voltage has been reapplied. The zero field 
incubation that results in this artifact is the basis of experiments designed to 
observe single enzyme molecules (22, 24). This artifact is observed at the end of 
the fluorescence plateau opposite of where one might expect it. Because the 
enzyme-substrate complex migrates to the LIF detector faster than the 
fluorescent product, the first product detected is product produced near the end 
of the experiment just as the enzyme-substrate complex migrates past the 
detector. The product produced when the enzyme is first injected into the 
capillary is actually detected last. In effect, all the electropherograms shown are 
reversed in time from what one would expect. This phenomenon has been 
described previously (25). 
It was determined experimentally that thermostatting was important in 
order to maintain a constant temperature and reaction rate throughout the 
capillary. The capillary was enclosed in a Teflon tube and heated N2 was 
circulated over the capillary in order to maintain a constant temperature. The 
temperature of the N2 was optimized for maximum activity (40 °C). Figure 2.2 
presents the data from an alkaline phosphatase enzyme assay without inhibitor 
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Figure 2.2. Electropherogram without thermostatting 
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due to changes in the temperature in different regions of the capillary which 
change the reaction rate as the enzyme zone passes through these regions. 
2.3.2 Capillary Electrophoretic Enzyme-Inhibitor Assay of Alkaline 
Phosphatase 
Figure 2.3 presents the data for the reversible inhibition of alkaline 
phosphatase by theophylline. In this experiment, 100 µM theophylline was 
injected first for 4.0 s at 1 7.8 kV (31 0 V/cm). Once theophylline was injected, 
then a constant potential of 1 7 .8 kV was applied for 20 .0 s. Next, 0 .18 nM 
alkaline phosphatase was injected for 3.0 s at 1 7.8 kV, and finally the separation 
potential of 1 7.8 kV was applied. As the zones of inhibitor and enzyme-substrate 
complex migrated through the capillary, product was formed continuously. When 
the zones of inhibitor and enzyme-substrate complex mixed electrophoretically, 
a decrease in product formation was observed due to the inhibition of the 
enzyme. Once the zones of inhibitor and enzyme-substrate complex separated 
again, the enzyme returned to its original activity indicating that theophylline is a 
reversible inhibitor. The reversible inhibition of alkaline phosphatase by 
theophylline is readily observed in the product plateau. 
Figure 2.3 (a)-(c) shows the relative positions of the enzyme and inhibitor 
zones in the capillary at the corresponding positions in the electropherogram. At 
(a), the inhibitor zone was injected first and then the enzyme zone. At (b), the two 
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Figure 2.3. Electropherogram of an alkal ine phosphatase--theophyl l ine 
enzyme-inhi bition assay 
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the inhibition of the enzyme. At (c), the two zones separated and the activity of 
the enzyme returned to its initial level. 
Theophylline was injected first because the enzyme-substrate complex 
has a greater mobility than the inhibitor. The injection order required to observe 
enzyme inhibition depends on the relative migration rates of the enzyme and 
inhibitor zones. In this case, theophylline migrates slower than the enzyme­
substrate complex. Therefore, theophylline is injected first to ensure that the two 
zones will mix in the capillary. If the inhibitor migrates faster than the enzyme­
substrate complex, the enzyme must be injected first to ensure mixing. Two 
experiments, at most, must be performed to detect an inhibitor of unknown 
electrophoretic mobility relative to the enzyme. If the inhibitor is injected first, and 
no inhibition is observed, a second experiment in which the enzyme is injected 
first should result in detection of inhibition. The exception to this would be in 
those rare instances where the inhibitor and enzyme have nearly identical 
electrophoretic mobilities. 
2.3.3 Theophylline Quantitation 
Theophylline is a noncompetitive, reversible inhibitor of alkaline 
phosphatase (56). Using Michaelis-Menten treatment of this system, the Km 
value will remain the same at any inhibitor concentration, but the apparent V max 
will change with the inhibitor concentration. The Michaelis-Menten equation is as 
follows: 
v I Vmax = [SJ I (Km + [SJ) 
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(2a) 
where v is the initial reaction velocity, Km is the Michaelis constant for the ES 
complex, and [SJ is the substrate concentration (64). A relative velocity equation 
can be derived for a noncompetitive inhibitor (64 ): 
Vmax*I Vmax = K; I (K; + [I}) (2b) 
where Vma/ is the apparent Vmax at a given inhibitor concentration, Vmax is the 
maximum velocity of the enzyme in the absence of an inhibitor, K; is the 
equilibrium constant for inhibitor binding to the enzyme, and [I] is the inhibitor 
concentration. Equation 2b can be rearranged to give the fol lowing equation: 
1 I Vma/ = (1 / Vmax KJ [I] + 1 1  Vmax (2c) 
A plot of 1Nma/ versus inhibitor concentration should be linear if the Michaelis­
Menten treatment is appropriate. 
An inhibitor response factor was defined in order to quantitate 
theophylline. The inhibitor response (Rice) for the capil lary electrophoresis 
experiments is: 
Rice = (F1 - Fo) I (F2 - Fo) (2d) 
The fluorescence at F1 (Figure 2.3) is proportional to the rate of product formation 
without inhibitor and is used to normalize the data due to variability in the 
magnitude of the plateau from experiment to experiment. F2 (Figure 2.3) is the 
fluorescence at the time when minimum product formation is observed, and the 
fluorescence is proportional to the velocity of product formation (dP/dt) during 
maximum inhibition. In all experiments, a saturating substrate concentration is 
used. Under these experimental conditions, dP/dt is Vmax •. The observed baseline 
signal for the experiment is F0 (Figure 2.3). Thus, Rice is proportional to 1N max·. 
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The Rice values at different theophylline concentrations have been plotted, and 
the results are shown in Figure 2.4. The K; value was determined to be 1 02 ± 4 
µM (R2 = 0.997) and is in agreement with reported literature values (57, 58). The 
detection limit for theophylline was 3 µM, and the linear dynamic range spanned 
from 5 µM to 250 µM. 
Similar experiments were also performed using a microplate reader. 
Figure 2.5 shows a plot of an analogous response factor for the microplate 
fluorometer, Rlmp, versus theophylline concentration for the microplate reader. 
Rlmp is equal to 1 /slope where slope is defined from the data obtained from the 
microplate reader. These data were obtained by monitoring the product formation 
at 0. 1 s intervals after the injection of alkaline phosphatase. The slope of the 
curve (fluorescence vs. time) was determined and is proportional to Vma/ The 
calculated K; for theophylline is 1 1 0 ± 5 µM (R2 = 0.997) for the microplate 
enzyme-inhibitor assays. This analysis of the data assumes steady-state kinetics. 
The data in Figure 2.5 suggest that the CE experiments exhibit steady-state 
behavior. 
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Figure 2.4. Plot of Rice versus theophyl l ine concentration 
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Chapter 3 
Capil lary Electrophoretic Analysis of Alkaline Phosphatase 
Inhibition by Irreversible and Competitive, Revers 1ible Inhibitors 
3.1 Introduction 
The first inhibitor of alkaline phosphatase studied was theophylline, which 
is a reversible, noncompetitive inhibitor of alkaline phosphatase. There are 
several other important classes of inhibitors, and in order to expand the utility of 
this technique, other classes of inhibitors were also studied. These inhibitors 
include competitive, reversible inhibitors, sodium vanadate and sodium arsenate, 
and the irreversible inhibitor, EDT A. 
Sodium vanadate is a competitive, reversible inhibitor of alkaline 
phosphatase (56, 6�7). Reported K; values for sodium vanadate range from 4 
µM for rat intestinal alkaline phosphatase (67) to 1 2  µM for Escherichia coli 
alkaline phosphatase (66). Vanadate is used in the treatment of diabetes since it 
mimics the effects of insulin and reduces glucose levels (68-70). In the body, 
vanadate affects the activity of several enzymes including adenylate cyclase, 
which regulates the levels of cyclic adenosine monophosphate. Cyclic adenosine 
monophosphate affects insulin secretion (70). Sodium arsenate, also a 
reversible, competitive inhibitor of alkaline phosphatase, was studied (56, 65, 67, 
71 ). Reported K; values for sodium arsenate range from 2 µM for rat intestinal 
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alkaline phosphatase (67) to 33.8 µM for membrane-bound alkaline phosphatase 
from bone cartilage (65). 
Alkaline phosphatase is a zinc metalloprotein and contains four 
equivalents of zinc per mole of alkaline phosphatase (56, 66, 72). Alkaline 
phosphatase often contains one equivalent of magnesium per mole of alkaline 
phosphatase (56). Zinc and magnesium are often added to commercial 
purchased preparations of alkaline phosphatase. Zinc is required for activity of 
the enzyme (73), but magnesium is not and it only activates the enzyme (56). If 
the magnesium is removed, the enzyme will function as normal but will not 
produce as much product, but if the zinc is removed, then enzyme will lose all 
activity. Chelating compounds such as EDTA can irreversibly inhibit alkaline 
phosphatase by removing the zinc from the enzyme (1 7, 74, 75). 
3.2 Experimental 
3.2. 1 Reagents 
Alkaline phosphatase (EC 3.1 .3 .1 from calf intestine) was purchased from 
ICN Biomedicals (Aurora, OH). AttoPhos ([2,2'-bibenzothiazol)-6-hydroxy­
benzathiazole phosphate) was obtained from Promega (Madison, WI). Sodium 
vanadate and diethanolamine (DEA) were supplied by Acros (Pittsburgh, PA). 
Disodium EDTA was purchased from Fisher Scientific. Sodium arsenate was 
supplied by Mallinckrodt (St. Louis, MO). All solutions and buffers were prepared 
in ultrapure water (>1 8 MQ·cm, Barnstead E-pure System, Dubuque, IA). 
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3.2.2 Experimental Conditions 
All experimental conditions for the assays by capillary electrophoresis and 
by the microplate reader presented in this chapter are identical to the 
experimental conditions described in detail in Chapter 2.2.2 and 2.2.3 .  
3.3 Results and Discussion 
3.3. 1 Alkaline Phosphatase Inhibition by Competitive, Reversible Inhibitors 
Figure 3.1 presents the data for a capillary electrophoretic enzyme­
inhibitor assay for sodium vanadate. Reversible inhibition of alkaline 
phosphatase by sodium vanadate is evident from these data when compared to 
Figure 2.2. Due to the greater mobility of alkaline phosphatase, sodium vanadate 
(75 µM) was injected first for 5.0 s at 17.8  kV (310 V/cm). Next a constant 
potential of 17.8  kV was applied for 50.0  s. Then 0.18 nM alkaline phosphatase 
was injected for 3 .0 s at 17.8  kV. Since sodium vanadate is a reversible inhibitor, 
the resulting product plateau (Figure 3 .1) is similar in appearance to the product 
plateau for theophylline inhibition as seen in Figure 2.3. All buffers were pH 9 .5 
and contained 50 mM d iethanolamine and 0 . 1 0  mM AttoPhos. The 
electrophoretic currents were typically 10 µA. 
According to the Michaelis-Menten treatment of a reversible, competitive 
inhibitor, V max is unaffected by the inhibitor, but the apparent Km, the Michaelis 
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Figure 3.1 . Electropherogram of a sodium vanadate-alka'l ine 
phosphatase enzyme-inhibitor assay 
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4.3 
determine the K; value of a competitive inhibitor (64). The equation used for the 
Dixon plot is as follows: 
1/v = (KrrN max[S]KJ[IJ + 1N max(1 +Krrl[S]) (3a) 
where v is the velocity of the reaction at inhibitor concentration, [I], V max is the 
maximum velocity of the enzyme at the concentration of substrate in absence of 
inhibitor, [SJ is the concentration of substrate, and K; is the equilibrium constant 
of the inhibitor binding to the enzyme. A plot of 1 /v versus [I] should be linear, 
and K; can be determined from the slope and intercept of the line and Vmax-
ln order to generate a Dixon plot for sodium vanadate, an inhibitor 
response factor, Rice, was defined for the capillary electrophoresis experiments 
as follows: 
Rice = (F1 - Fo)l(F2 - Fo) (3b) 
where F1 (Figure 3.1 ) is proportional to the rate of product formation without 
inhibitor and is used to normalize the data due to variability in the height of the 
plateau from experiment to experiment. F2 (Figure 3.1 ) is the minimum product 
formation observed in the plateau. F0 is the baseline fluorescence (Figure 3.1 ). 
Rice is proportional to 1 /v in Equation 3a. A similar approach was used to analyze 
theophylline in Chapter 2.3.3. In Figure 3.2, Rice values at different 
concentrations of sodium vanadate have been plotted. In order to determine K; 
for sodium vanadate, V max is required. V max is determined from the Rice value of 
the capillary electrophoretic assay without inhibitor (Figure 2.1 ). The K; was 
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Figure 3.2. A plot of Rice versus sodium vanadate concentration 
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3.2 (R2 = 0.997). The detection limit for sodium vanadate was 3 µM. 
Microplate fluorometer experiments analogous to the capillary 
electrophoretic enzyme-inhibitor assays were performed. A response factor, 
Rlmp, for the microplate fluorometer was defined as 1 /v where 1 /v is the inverse of 
the initial velocity of the enzyme-catalyzed reaction. The slope of the plot of 
fluorescence versus time for the microplate experiments is used to determine v. 
Figure 3.3 shows the Dixon Plot, Rlmp versus concentration of sodium vanadate, 
for the microplate experiments. V max is determined by carrying out experiments to 
generate a Lineweaver-Burk Plot as defined by the equation below (64): 
1/v = (Krr/Vmax)(1/[S]) + 1Nmax (3c) 
A plot of 1 /v versus 1 /[S] should be linear, and V max can be determined from the 
inverse of the intercept. From the slope and intercept of the line and the Vmax 
value, the K; was determined to be 3.5 ± 0.2 µM for sodium vanadate (R2 = 
0.998). The analysis of the sodium vanadate data assumed steady-state kinetics, 
and comparison of the results from the capillary electrophoretic enzyme-inhibitor 
assays to the microplate assays, indicated that the capillary electrophoretic 
enzyme-inhibitor assays exhibited steady-state behavior. The K; values for the 
capillary electrophoretic and microplate enzyme-inhibitor assays are in 
agreement with reported values (66, 67). 
An electropherogram from a capillary electrophoretic enzyme-inhibitor 
assay of the reversible inhibition of alkaline phosphatase by sodium arsenate is 
presented in Figure 3.4. In this experiment, 125 µM sodium arsenate was 






0 20 40 60 80 
Sodium Vanadate Concentration (µM) 













0 ........ --------------------------t 
3.6 3.8 4 
T ime (min) 
4.2 4.4 
Figure 3.4. Electropherogram of a sodium ars,enate-alkal ine phosphatase 
enzyme-inhibitor assay 
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has a greater mobility than arsenate. Then a constant potential of 1 7. 8  kV was 
appl ied for 1 50.0 s. Alkal ine phosphatase (0. 1 8  nM) was injected for 3 .0 s at 1 7. 8  
kV before the appl ication of the separation potential (1 7 .8 kV) . Since sodium 
arsenate is a reversible , competitive inh ibitor, its response is similar to that for 
sodium vanadate. 
The kinetic treatment of the capil lary electrophoretic enzyme-inhibitor 
assay data for sodium arsenate was the same as for sodium vanadate. The plot 
of Rice at different concentrations of sodium arsenate (25 to 250 µM; N = 3) was 
l inear (R2 = 0.999) , ind icating that the arsenate assays exhibited steady-state 
behavior. The K; for sodium arsenate was 21  ± 4 µM. Microplate fluorometer 
experiments were performed for sodium arsenate, and the kinetic treatment of 
the data was the same as for sodium vanadate. The K; for sod ium arsenate for 
the microplate fluorometer was determined to be 8.6 ± 1 .4 µM. The K; values for 
the CE and microplate fluorometer enzyme-inhibitor assays are in agreement 
with reported values for sodium arsenate. It is unclear why the K; value 
determined for sodium arsenate using CE is a factor of two higher than the K; 
determined using microplate experiments . This could be a kinetic effect since the 
electrophoretic experiment takes place on a faster time scale than the microplate 
experiments . However, the capil lary electrophoretic data for sod ium arsenate 
gave an excellent fit to the equation for the Dixon plot, and the K; values obtained 
for other reversible inhibitors (vanadate and theophyl l ine) were similar using both 
techniques. 
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3.3.2 Alkaline Phosphatase Inhibition by an Irreversible Inhibitor 
Alkaline phosphatase is a zinc metalloprotein and contains four 
equivalents of zinc per mole of alkaline phosphatase (56, 66, 72). Zinc is required 
for activity of the enzyme (73). Chelating compounds such as EDTA can 
irreversibly inhibit alkaline phosphatase by removing the zinc from the enzyme 
(17, 74, 75). A capillary electrophoretic enzyme-inhibitor assay indicating 
irreversible inhibition of alkaline phosphatase by EDTA is shown in Figure 3 .5. In 
this experiment, 1.0 mM EDTA was injected first for 55.0 s at 17.8 kV (310 V/cm). 
Next a constant potential of 17.8 kV was applied for 180.0 s. Then 0.18 nM 
alkaline phosphatase was injected for 3.0 s at 17.8 kV. As presented in Figure 
3.5, product formation decreased when the zones of inhibitor and enzyme­
substrate complex mixed electrophoretically (4.2 min, Figure 3.5). After the zones 
of inhibitor and enzyme-substrate complex separated, the enzyme did not return 
to its original activity (4.0 min, Figure 3.5), indicating that the enzyme was 
irreversibly inhibited. The same experiment using 0.030 mM EDTA is presented 
in Figure 3.6. At this EDTA concentration, when the enzyme-substrate complex 
and inhibitor separated , the enzyme was activated rather than irreversibly 
inhibited. 
In order to quantify to what extent alkaline phosphatase was irreversibly 
inhibited or activated by EDTA, the ratio of enzyme activity before and after the 
enzyme interacted with EDTA was measured over a range of EDTA 
concentrations. The fractional activity is calculated as follows: 
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Figure 3.6.  Activation of alkal ine phophatase by 0.030 m1M EDTA 
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4.7 
where /1 (Figure 3.6) is the activity of alkal ine phosphatase after interacting with 
EDT A, /2 is the activity of alkal ine phosphatase before interacting with EDTA, and 
/0 is the basel ine fluorescence. Figure 3. 7 presents the fractional activity versus 
EDTA concentration from 1 0  µM to 4.0 mM. The dotted l ine is the fractiona'I 
activity measured for control assays (Figure 2 .2) .  Fractional activity va lues above 
this l ine indicate inhibition . Concentrations of EDTA at 1 . 0 mM and higher 
irreversibly inh ibit alka l ine phosphatase. Concentrations from 20 to 400 µM 
EDTA activate a lka l ine phosphatase. The maximum activation is observed at 40 
µM . EDTA is thought to irreversibly inhibit alkaline phosphatase by bind ing to the 
zinc bound to the enzyme and then removing the zinc, leaving the enzyme 
inactivated ( 17 , 75). The mechanism by wh ich EDTA activates alkal ine 
phosphatase is unknown . 
Activation of alkal ine phosphatase by EDT A has been reported for human 
placental alka line phosphatase at concentrations of 1 0  to 1 00 mM EDTA (1 6) ,  for 
Gastrothylax crumenifer and Cotylophoron orientale alkal ine phosphatases at 1 .  O 
mM EDTA (76) , and for Ascaris suum alkaline phosphatase at 1 0  mM EDTA 
(77). However, the alka l ine phosphatases used in al l three of these stud ies were 
in crude preparations, and it was not clear what other enzymes were present in 
these preparations . Only one alkal ine phosphatase was from a mammal ian 
source (human placental) ,  and this showed inhibition at low EDTA concentrations 
(1 0 µM to 1 mM) and activation at high EDTA concentrations ( 1 0  to 1 00 mM).  
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Figure 3. 7. A plot of fractional activity versus concentration 
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phosphatase where activation was observed at low EDTA concentrations (20 to 
400 µM) ,  and inhibition was observed at high EDTA concentrations ( 1 .0  mM or 
h igher) .  It has also been reported that purified human placenta l alkaline 
phosphatase was only inactivated by EDTA (5 to 40 mM) and not activated by 
EDTA at any concentration (78) . 
One possible explanation for these resu lts, unrelated to the abil ity of 
EDTA to chelate zinc, is ionic strength effects of the EDTA injection zone on 
alkaline phosphatase (79, 80). In order to determine whether or not the ion ic 
strength of the EDTA zone was causing the observed irreversible inhibition and 
activation of alkal ine phosphatase , the same experiments were performed with 
sod ium chloride replacing EDT A. The ionic strength of the sod ium chloride 
solutions is the same as the EDT A solutions used in the experiments presented 
in Figure 3. 7. A plot of fractional activity versus ion ic strength is presented in 
Figure 3 .8 .  The open circles represent the fractional activity for EDTA, and the 
closed circles represent the fractional activity for sodium chloride. The dotted l ine 
is the fractional activity measured for control assays (Figure 2 .2). These 
experiments ind icate that the change in ion ic strength due to EDTA does not 
cause the observed inhibition of alkal ine phosphatase. However, the activity 
increase is less than that observed for EDTA at al l  ionic strengths. For example, 
at an ionic strength of 0.66 mM,  the fractional activity of the enzyme increased by 
4% for sodium ch loride and increased by 32% for EDT A. At an ion ic strength of 
1 .32 mM,  the fractional activity of the enzyme increased by 4% for sodium 
chloride and increased by 1 8  % for EDT A. At an ionic strength of 26.5  mM, the 
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Figure 3.8. A plot of fractional activity versus ion ic strength. The 
open circles represent the fractional activity for EDTA, and the 
closed circles represent the fractional activity for sodium chloride. 
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fractional activity of the enzyme increased by 17% for sodium chloride and 
decreased by 83% for EDTA. It has been reported that the addition of some 
salts, including sodium chloride, increases the activity of E. coli alkaline 
phosphatase (80) . However, activation of the magnitude observed at low EDTA 
concentrations here cannot be attributed to only ionic strength. 
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Chapter 4 
Conclusions and Future Work 
4.1 Conclusions 
An on-column capillary electrophoretic enzyme-inhibition assay has been 
developed to study different types of inhibition, reversible and irreversible, and 
activation. Competitive and noncompetitive reversible inhibitors can be analyzed 
quantitatively using Michaelis-Menten treatment of the capillary electrophoretic 
data. Fractional activity of irreversible inhibitors and activators can also be 
determined. Using this approach, reversible inhibition, irreversible inhibition and 
activation can be readily distinguished by only visual inspection of single 
electropherograms and comparison to control electropherograms. 
The inhibition of alkaline phosphatase by the noncompetitive, reversible 
inhibitor, theophylline, was studied using capillary electrophoresis. The calculated 
K; for theophylline is 102 ± 4 µM for the capillary electrophoretic enzyme­
inhibition assays and is in agreement with literature values. The inhibition of 
alkaline phosphatase by the competitive reversible, inhibitors sodium vanadate 
and sodium arsenate resulted in calculated K; values of 2.1 ± 1 .5 µM and 21 ± 4 
µM for the capillary electrophoretic enzyme-inhibition assays. The K; values 
determined for vanadate and arsenate using the CE method are consistent with 
values determined using traditional enzyme assays in a microplate reader and 
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with literature values. Irreversible inhibition as well as activation by EDTA was 
observed for the capillary electrophoretic enzyme-inhibition assays. 
Only 1.9 attomoles of alkaline phosphatase was required for the CE 
experiment, whereas 36 femtomoles of alkaline phosphatase was required for 
analogous experiments using a microplate fluorometer (200 µL sample volume). 
The capillary electrophoretic enzyme-inhibition assays give more information per 
experiment as compared to traditional methods including the microplate enzyme­
inhibition assays as well as consu�ing less enzyme per experiment (104 less 
compared to microplate experiments). From visual inspection alone, the type of 
inhibition (reversible or irreversible) or activation can easily be identified. Other 
information is also provided from the electropherogram that traditional enzyme 
assays do not provide. Traditional methods allow one to see the activity of the 
enzyme while it is interacting with the inhibitor, but the capillary electrophoretic 
assays allow one to see the activity of the enzyme before interacting with the 
inhibitor or activator, the activity of the enzyme while it interacts with the inhibitor, 
and the activity of the enzyme after interacting with the inhibitor. The capillary­
electrophoretic assays provide greater insight of the enzyme activity after being 
separated from the inhibitor or activator that traditional methods do not allow. 
Other information can also be obtained from the electropherogram of an enzyme­
inhibition assay including velocity of the enzyme-substrate complex, product, 
and inhibitor, the time the inhibitor and enzyme interact, and where in the 
capillary the enzyme and inhibitor interact (equations are in the Appendix). 
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Inhibition and activation of alkaline phosphatase has been observed using the 
developed capillary electrophoretic enzyme-inhibition assays. 
4.2 Future Studies 
Future studies should include studying the mechanism of the EDTA 
inhibition and activation by developing more mathematical descriptions of these 
assays to expand the quantitative information that can be obtained from the 
electropherograms. Microplate assays can also be performed with EDTA to 
gather more information about how EDTA interacts with alkaline phosphatase. 
The data obtained from the microplate should be further analyzed by 
mathematical treatment of irreversible inhibition kinetics that has been reported in 
the literature (1 8, 81 ). Also the mechanism of the EDTA inhibition and activation 
should be compared to other similar chelators. Some possibilities of chelators are 
ethylene glycol-bis(2-aminoethyl)-N,N,N',N'-tetraacetic acid (EGTA), nitriloacetic 
acid (NTA), and 1 ,  1 0-phenanthroline. Comparison of the fractional activity of 
these to the fractional activity of EDTA will provide insight to how chelators 
interact with alkaline phosphatase on a short time scale. Reactivation of alkaline 
phosphatase after interact with EDT A or other chelators can also be explored by 
injecting a separate zone of zn+2 along with the zones of EDTA (or other 
chelator) and alkaline phosphatase. Activation of alkaline phosphatase by 
reported activators in the literature should also be explored (56). From 
preliminary data, sodium cyanide and cysteine are promising activators to study. 
Studying the theoretical interaction times versus the experimentally determined 
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interaction times of the inhibitor and enzyme by using the derived equations in 
the Appendix should be compared in order to describe how the enzyme and 
inhibitor interact in the capil lary. Other enzymes and their important inh ibitors 
should also be stud ied to demonstrate the versatil ity of these enzyme-inhibition 
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Figure A. 1 .  Electropherogram with relative times noted for calculation . of 
quantitative information 
Defined Variables 
d = distance from the injection end where the enzyme and inhibitor interact 
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Lei = distance to the detector window 
t = time that the enzyme and inhibitor interact 
tEs = time that the enzyme-substrate complex is detected as it migrates past the 
detector window 
t1p = time that the inhibition product is detected 
tp = time that that the first product formed 
,ME&t = time difference between the injection of the inhibitor and the enzyme 
VEs = velocity of the enzyme-substrate complex = Lci/tEs 
v, = velocity of the inhibitor 
Vp = velocity of the product = LitP 
Ate&1 Flow 
� ... 
ES I I I � 
X Detector window 
< > 
Figure A.2. A cross view of a capillary and the relative positioning of the 
inhibitor and enzyme-substrate complex zones 
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I n  the experiments presented here, the inh ibitor zone is always injected first 
because it has a lower mobil ity than the enzyme-substrate (ES) complex zone. 
The inhibitor zone wi l l  m igrate through the capi l lary for some given time, .ME&1 , 
and wi ll travel some d istance, x, before the enzyme is injected . The enzyme is 




< > � 







Figure A.3. A cross view of a capil lary showing how far and how long the 
enzyme-substrate complex and inhibitor zones travel after the enzyme is 
injected in order for the zones to mix electrophoretically 
As seen in Figure A.3,  the inhibitor zone and the ES complex zone wil l  travel the 
same time , t, to electrophoretical ly mix in the capi l lary. The ES complex zone 
travels the d istance, d ,  to meet the inhibitor zone, and the d istance,  y, is how far 
the the inhibitor zone travels when the ES complex zone meets the inhibitor 
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zone. We can derive the exact time, t, that the ES complex zone and inhibitor 
zone mix electrophoretical ly. Below is the derivation . 
We know the fol lowing equations based Figures A.2 and A.3 above: 
d = X + y X = v, • ,Me&I y = t • v, 
d = t • Ves 
We know that d = x + y and d = t • Ves. Both can be set equal to each other as 
fol lows: 
t • Ves = x + y 
Substitute in x = v, • Ate&1 into Equation Aa. 
t • Ves = v, • Ate&1 + y 
Substitute in y = t • v, into Equation Ab. 
t • Ves = v, • Ate&1 + t • v, 
Rearrange Equation Ac and solve for t. 
t (ves - v,) = v, • Ate&1 
Equation 1 :  Time that the inhibitor and enzyme interact 





We must also solve for the time, t, where the enzyme and inhibitor zones mix 
electrophoretical ly in  the capi l lary based on the time that the inhibition product 








Figure A.4. Distance traveled by the inhibition product, IP  
The inhibition product, IP, is formed where the ES complex and inhibitor zones 
mixed electrophoretically at the distance, d. The IP zone travels the distance, z, 
over the time, t,P·, to be detected at the detector window. The ES complex zone 
travels the distance, z, over time tEs·, to be detected at the detector window. We 
know the following based on Figure A.4: 
Z = t1p• • Vp 
We can set the two equations above that each equal z equal to each other as 
follows: 
(Ae) 
We know that the total time that the ES complex zone migrates through the 
capillary is equal to the following: 
(Af) 
The Equation Af can be rearranged to solve for tEs • substituted into Equation Ae 
as follows: 
(tEs - t) VEs = tip • •  Vp (Ag) 
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The total time required to observe the inhibition product, tip , is equal to the 
following: 
t1p = t + t1p* (Ah) 
The Equation Ah can be rearranged to solve for tip* and substituted into Equation 
Ag as follows: 
(tEs - t) VEs = (t1p - t) Vp (Ai) 
Rearrange Equation Ai and solve for t. 
t = (t1p • Vp - tEs • VEs) / (Vp - VEs) (Aj) 
Equation Aj can be simplified down to an equation to solve for the time that the 
inhibition product is formed by only requiring the times tEs, tp , and t1p from the 
electropherogram (Figure A. 1 ). Substitute the fo llowing into Equation Aj: 
VEs • tEs = Ld Vp = Ld / tp VEs = Ld / tEs 
After the substitutions into Equation Aj and simplifying , the fol lowing equation 
results: 
Equation 2: Time the inh ibition product forms 
t = [tes (tap - tp)] / (tes - tp) 
We can also determine the velocity of the inhibitor, v1 •  We know the fol lowing 
based in Figure A.2: 
V1 = Y / t (Ak) 
Substitute y = d - x into Equation Ak. 
V 1 = (d - X) / t (Al) 
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Substitute x = v, • ,ME&I into Equation Al. 
V1 = ( d - V1 • ,ME&I) / t 
Substitute d = VEs • t into Equation Am. 
V1 = (VEs • t - V1 • ,ME&I) / t 
Rearrange Equation An, solve for v1 , and the following equation results: 
Equation 3 :  Velocity of inhibitor zone 
v, = (Yes • t) / (t + Lile&1) 
(Am) 
(An) 
From equations 1 -3 and the times from the electropherogram from Figure A. 1 ,  
the times and velocity of each zone (ES complex zone, inhibitor zone, and 
inhibition product) can be determined. 
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